Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
United States: Food and Drug Administration
PTH-303
NCT00083252
Name | Location |
---|---|
Carolinas Medical Center | Charlotte, North Carolina 28232-2861 |
Mary Crowley Medical Research Center | Dallas, Texas 75246 |
Tyler Cancer Center | Tyler, Texas 75702 |
University of Colorado Health Sciences Center | Denver, Colorado 80262 |
Cancer Center of the Carolinas | Greenville, South Carolina 29615 |
NYU School of Medicine | New York, New York 10016 |
University of Arkansas Medical Sciences | Little Rock, Arkansas 72205 |
Cancer Center of Florida | Ocoee, Florida 34761 |
Indiana Hematology Oncology Consultants | Indianapolis, Indiana 46202 |
Cancer Institute Medical Group, Inc. | Santa Monica, California 90404 |
New Mexico Cancer Center Alliance | Albuquerque, New Mexico 87106 |
Fifth Avenue Medical Healthcare | New York, New York 10128 |
Cancer Care Northwest Research | Spokane, Washington 99218 |